| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0181-5512(04)96096-2 |
| P698 | PubMed publication ID | 14968082 |
| P2093 | author name string | C J Pournaras | |
| P2860 | cites work | Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami | Q30666539 |
| Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes | Q30825326 | ||
| Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. | Q30988238 | ||
| Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. | Q31118256 | ||
| Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial | Q33267227 | ||
| Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. | Q33874898 | ||
| Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study | Q33874902 | ||
| Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin | Q34294066 | ||
| Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. | Q34940940 | ||
| Occult choroidal neovascularization in age-related macular degeneration. A natural history study | Q36851018 | ||
| Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4. | Q44222596 | ||
| Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin | Q56812915 | ||
| Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67660771 | ||
| Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67702243 | ||
| Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67702246 | ||
| Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group | Q68957138 | ||
| Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group | Q71618232 | ||
| Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group | Q72683487 | ||
| A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes | Q73559495 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | French | Q150 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 72-74 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal Francais d'Ophtalmologie | Q15749105 |
| P1476 | title | [Photodynamic therapy. Foreword ]. | |
| P478 | volume | 27 |
Search more.